These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 25398067)

  • 41. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial.
    Deutsch MB; Glidden DV; Sevelius J; Keatley J; McMahan V; Guanira J; Kallas EG; Chariyalertsak S; Grant RM;
    Lancet HIV; 2015 Dec; 2(12):e512-9. PubMed ID: 26614965
    [TBL] [Abstract][Full Text] [Related]  

  • 42. FDA paves the way for pre-exposure HIV prophylaxis.
    Holmes D
    Lancet; 2012 Jul; 380(9839):325. PubMed ID: 22852138
    [No Abstract]   [Full Text] [Related]  

  • 43. Sexual Relationships Outside Primary Partnerships and Abstinence Are Associated With Lower Adherence and Adherence Gaps: Data From the Partners PrEP Ancillary Adherence Study.
    Kintu A; Hankinson SE; Balasubramanian R; Ertel K; Tumwesigye E; Bangsberg DR; Haberer JE;
    J Acquir Immune Defic Syndr; 2015 May; 69(1):36-43. PubMed ID: 25942457
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pre-exposure prophylaxis (PrEP) in HIV-uninfected individuals with high-risk behaviour.
    Nadery S; Geerlings SE
    Neth J Med; 2013; 71(6):295-9. PubMed ID: 23956310
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preexposure prophylaxis will have a limited impact on HIV-1 drug resistance in sub-Saharan Africa: a comparison of mathematical models.
    van de Vijver DA; Nichols BE; Abbas UL; Boucher CA; Cambiano V; Eaton JW; Glaubius R; Lythgoe K; Mellors J; Phillips A; Sigaloff KC; Hallett TB
    AIDS; 2013 Nov; 27(18):2943-51. PubMed ID: 23939237
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oral antiretroviral chemoprophylaxis: current status.
    Baeten J; Celum C
    Curr Opin HIV AIDS; 2012 Nov; 7(6):514-9. PubMed ID: 22964886
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice.
    Denton PW; Estes JD; Sun Z; Othieno FA; Wei BL; Wege AK; Powell DA; Payne D; Haase AT; Garcia JV
    PLoS Med; 2008 Jan; 5(1):e16. PubMed ID: 18198941
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Australian gay men who have taken nonoccupational postexposure prophylaxis for HIV are in need of effective HIV prevention methods.
    Zablotska IB; Prestage G; Holt M; Poynten M; de Wit J; Guy R; Mao L; McAllister J; Grulich AE
    J Acquir Immune Defic Syndr; 2011 Dec; 58(4):424-8. PubMed ID: 21857349
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changes in glomerular kidney function among HIV-1-uninfected men and women receiving emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis: a randomized clinical trial.
    Mugwanya KK; Wyatt C; Celum C; Donnell D; Mugo NR; Tappero J; Kiarie J; Ronald A; Baeten JM;
    JAMA Intern Med; 2015 Feb; 175(2):246-54. PubMed ID: 25531343
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Knowledge of and opinions on HIV preexposure prophylaxis among front-line service providers at Canadian AIDS service organizations.
    Senn H; Wilton J; Sharma M; Fowler S; Tan DH
    AIDS Res Hum Retroviruses; 2013 Sep; 29(9):1183-9. PubMed ID: 23731254
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preexposure Prophylaxis with Tenofovir/Emtricitabine Prevents HIV Infection In Men who Have Unprotected Anal Intercourse.
    Ebell MH
    Am Fam Physician; 2016 Mar; 93(6):520. PubMed ID: 26977839
    [No Abstract]   [Full Text] [Related]  

  • 52. Human Immunodeficiency Virus/Sexually Transmitted Infection Counseling and Testing Services Received by Gay and Bisexual Men Using Preexposure Prophylaxis at Their Last PrEP Care Visit.
    Parsons JT; John SA; Whitfield THF; Cienfuegos-Szalay J; Grov C
    Sex Transm Dis; 2018 Dec; 45(12):798-802. PubMed ID: 30422969
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Non-occupational HIV post-exposure prophylaxis at a Sydney metropolitan sexual health clinic.
    Gulholm T; Jamani S; Poynten IM; Templeton DJ
    Sex Health; 2013 Nov; 10(5):438-41. PubMed ID: 23962489
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Raltegravir-emtricitabine-tenofovir as HIV nonoccupational post-exposure prophylaxis in men who have sex with men: safety, tolerability and adherence.
    McAllister J; Read P; McNulty A; Tong WW; Ingersoll A; Carr A
    HIV Med; 2014 Jan; 15(1):13-22. PubMed ID: 24007390
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cost-effectiveness of pre-exposure prophylaxis (PrEP) in preventing HIV-1 infections in rural Zambia: a modeling study.
    Nichols BE; Boucher CA; van Dijk JH; Thuma PE; Nouwen JL; Baltussen R; van de Wijgert J; Sloot PM; van de Vijver DA
    PLoS One; 2013; 8(3):e59549. PubMed ID: 23527217
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A perspective on progress and gaps in HIV prevention science.
    Kiser PF; Mesquita PM; Herold BC
    AIDS Res Hum Retroviruses; 2012 Nov; 28(11):1373-8. PubMed ID: 22966871
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Disinhibition and risk compensation: scope, definitions, and perspective.
    Hogben M; Liddon N
    Sex Transm Dis; 2008 Dec; 35(12):1009-10. PubMed ID: 18936724
    [No Abstract]   [Full Text] [Related]  

  • 58. Emtricitabine + tenofovir to prevent HIV transmission. More evaluation needed.
    Prescrire Int; 2013 Jul; 22(140):178-81. PubMed ID: 23951592
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The risk of HIV drug resistance following implementation of pre-exposure prophylaxis.
    van de Vijver DA; Boucher CA
    Curr Opin Infect Dis; 2010 Dec; 23(6):621-7. PubMed ID: 20847692
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antiretroviral Pre-Exposure Prophylaxis Does Not Enhance Immune Responses to HIV in Exposed but Uninfected Persons.
    Pattacini L; Murnane PM; Baeten JM; Fluharty TR; Thomas KK; Bukusi E; Katabira E; Mugo N; Donnell D; Lingappa JR; Celum C; Marzinke M; McElrath MJ; Lund JM;
    J Infect Dis; 2015 Jun; 211(12):1943-52. PubMed ID: 25520426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.